Hyperlipemia Clinical Trials
Conditions / Hyperlipemia
Delta Trials catalogs 11 clinical trials for Hyperlipemia in its publicly accessible dataset. Within this set, 0 currently recruiting participants and 9 trials have reached completion. This research occurs across 40 participating sites around the world. An additional 2 trials are in other active phases such as not yet recruiting or pending status. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
11
Total Trials
0
Recruiting
9
Completed
2
Other Active
0
Terminated since 2020
40
Study Locations
Browse by location (40 total)
- Beijing, China 6 trialsAll trials in Beijing, China
- Tianjin, China 2 trialsAll trials in Tianjin, China
- Xuzhou, China 2 trialsAll trials in Xuzhou, China
- Chongqing, China 2 trialsAll trials in Chongqing, China
- Changchun, China 2 trialsAll trials in Changchun, China
- Zhengzhou, China 2 trialsAll trials in Zhengzhou, China
- Dalian, China 2 trialsAll trials in Dalian, China
- Fuzhou, China 2 trialsAll trials in Fuzhou, China
- Jingzhou, China 2 trialsAll trials in Jingzhou, China
- Wenzhou, China 2 trialsAll trials in Wenzhou, China
- Jinzhou, China 2 trialsAll trials in Jinzhou, China
- Xianyang, China 2 trialsAll trials in Xianyang, China
- Daqing, China 2 trialsAll trials in Daqing, China
- Nanchang, China 2 trialsAll trials in Nanchang, China
- Changsha, China 2 trialsAll trials in Changsha, China
- Taizhou, China 2 trialsAll trials in Taizhou, China
- Guangzhou, China 2 trialsAll trials in Guangzhou, China
- Changzhou, China 2 trialsAll trials in Changzhou, China
- Shenzhen, China 1 trialAll trials in Shenzhen, China
- Nanning, China 1 trialAll trials in Nanning, China